| Accession Number: | 0000899243-21-035224 |
| Date: | 2021-09-01 |
| Issuer: | GLOBAL BLOOD THERAPEUTICS, INC. (GBT) |
| Original Submission Date: |
CHOI JUNG
C/O GLOBAL BLOOD THERAPEUTICS, INC.
181 OYSTER POINT BLVD.
SOUTH SAN FRANCISCO, CA 94080
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | 2021-08-31 | A | 128 | a | $24.39 | 182,495 | direct | ||
| COMMON STOCK | 2021-09-01 | M | 2,762 | a | $0.00 | 185,257 | direct | ||
| COMMON STOCK | 2021-09-01 | F | 1,370 | d | $29.85 | 183,887 | direct | ||
| COMMON STOCK | 2021-09-01 | 0 | $0.00 | 25,000 | indirect |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RESTRICTED STOCK UNITS | 0.0 | 2021-09-01 | deemed execution date | M | 2,762 (d) | common stock 2,762 | $0.00 | 19,340 | direct |
| ID | footnote |
|---|---|
| f1 | shares acquired pursuant to the issuer's amended and restated 2015 employee stock purchase plan in transactions that were exempt under both rule 16b-3(d) and rule 16b-3(c). |
| f2 | each restricted stock unit ("rsu") represents the right to receive one share of the issuer's common stock. |
| f3 | represents number of shares of issuer's common stock withheld to satisfy the reporting person's tax obligations in connection with the vesting of 2,762 shares of common stock underlying the reporting person's rsus. |
| f4 | the shares of common stock underlying the rsus vest in 8 equal semi-annual installments over 4 years from march 1, 2021, so long as the reporting person continues as an employee or other service provider of the issuer through each vesting date. the rsus are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the issuer. |
